ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near San Antonio, TX, USA:

Locations recently updated

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...

Enrolling
Ovarian Cancer
Drug: Carboplatin
Drug: ABBV-901

Phase 1

AbbVie
AbbVie

San Antonio, Texas, United States and 21 other locations

Ovarian cancer is a lethal disease with an estimated 310,000 new cases and 200,000 deaths experienced worldwide in 2020. The purpos ...

Enrolling
Ovarian Cancer
Drug: Bevacizumab
Drug: Mirvetuximab Soravtansine

Phase 2

AbbVie
AbbVie

San Antonio, Texas, United States and 83 other locations

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

San Antonio, Texas, United States and 46 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

San Antonio, Texas, United States and 106 other locations

(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...

Enrolling
Epithelial Ovarian Cancer
Drug: Topotecan
Drug: Mirvetuximab Soravtansine (MIRV)

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 298 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 73 other locations

phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian...

Enrolling
Ovarian Cancer
Solid Tumor
Drug: CUSP06

Phase 1

OnCusp Therapeutics

San Antonio, Texas, United States of America and 14 other locations

Locations recently updated

as a monotherapy and in combination with bevacizumab (or a biosimilar) in patients with locally advanced or metastatic solid tumors, including ovarian...

Enrolling
High-grade Serous Ovarian Carcinoma
Squamous Non-small-cell Lung Cancer
Drug: ATX-295
Drug: ATX-295 and bevacizumab (or biosimilar)

Phase 1, Phase 2

Accent Therapeutics

San Antonio, Texas, United States and 9 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the s...

Enrolling
Primary Peritoneal Cancer
Epithelial Ovarian Cancer
Drug: Mirvetuximab Soravtansine
Drug: Bevacizumab

Phase 2

AbbVie
AbbVie

San Antonio, Texas, United States and 69 other locations

HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody...

Enrolling
Endometrial Cancer
Ovarian Cancer Metastatic Recurrent
Drug: HWK-007

Phase 1

Whitehawk Therapeutics, Inc.

San Antonio, Texas, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems